Literature DB >> 14741426

Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).

Garth E Ringheim1, Katherine Conant.   

Abstract

The appearance of activated immune cells and the accumulation of inflammation-associated proteins are common phenomena associated with neurodegenerative diseases. These inflammatory components of central nervous system (CNS) diseases have most often been described in the context of an immune response to damage and cell loss already occurring in the affected brain area. There has, however, been a renewed interest in how the neuroimmune axis might itself be involved in the etiology of these neurodegenerative diseases, particularly in cases involving slow, chronic, progressive neuropathology. This review addresses immune activation in Alzheimer's, Parkinson's, and brain viral infections that may be causative of, rather than responsive to, the observed neuronal loss in these pathologies.

Entities:  

Mesh:

Year:  2004        PMID: 14741426     DOI: 10.1016/j.jneuroim.2003.10.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  26 in total

1.  A much convenient and economical method to harvest a great number of microglia.

Authors:  Kun Qin; Ye-Hai Li; Ge Tian; Wei-Wei Xu; Peng Li; Run Zhang; Zheng-Yang Li; Xiao-Dan Jiang
Journal:  Cell Mol Neurobiol       Date:  2011-07-16       Impact factor: 5.046

Review 2.  Immunology and neurology.

Authors:  Eilhard Mix; Robert Goertsches; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

3.  Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations.

Authors:  Mitzi M Gonzales; Takashi Tarumi; Danielle E Eagan; Hirofumi Tanaka; Miral Vaghasia; Andreana P Haley
Journal:  Psychosom Med       Date:  2012-07-20       Impact factor: 4.312

Review 4.  Alzheimer's disease, brain immune privilege and memory: a hypothesis.

Authors:  Y I Arshavsky
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

Review 5.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

6.  Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.

Authors:  Wei-Ching Huang; Yee-Shin Lin; Chi-Yun Wang; Cheng-Chieh Tsai; Hsiang-Chi Tseng; Chia-Ling Chen; Pei-Jung Lu; Po-See Chen; Li Qian; Jau-Shyong Hong; Chiou-Feng Lin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

7.  Infectious burden and cognitive function: the Northern Manhattan Study.

Authors:  Mira Katan; Yeseon Park Moon; Myunghee Cho Paik; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  Neurology       Date:  2013-03-26       Impact factor: 9.910

8.  Monocyte Phenotype and Polyfunctionality Are Associated With Elevated Soluble Inflammatory Markers, Cytomegalovirus Infection, and Functional and Cognitive Decline in Elderly Adults.

Authors:  Rebeca Sara de Pablo-Bernal; Julio Cañizares; Isaac Rosado; María Isabel Galvá; Ana Isabel Alvarez-Ríos; Antonio Carrillo-Vico; Sara Ferrando-Martínez; María Ángeles Muñoz-Fernández; Mohammed Rafii-El-Idrissi Benhnia; Yolanda María Pacheco; Raquel Ramos; Manuel Leal; Ezequiel Ruiz-Mateos
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-18       Impact factor: 6.053

9.  Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

Authors:  Shulamit Naor; Zohar Keren; Tomer Bronshtein; Efrat Goren; Marcelle Machluf; Doron Melamed
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

10.  Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.

Authors:  Amber Watts; Eileen M Crimmins; Margaret Gatz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.